These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8611394)

  • 1. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells.
    Homolya L; Holló M; Müller M; Mechetner EB; Sarkadi B
    Br J Cancer; 1996 Apr; 73(7):849-55. PubMed ID: 8611394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
    Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
    Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.
    Holló Z; Homolya L; Hegedûs T; Müller M; Szakács G; Jakab K; Antal F; Sarkadi B
    Anticancer Res; 1998; 18(4C):2981-7. PubMed ID: 9713496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcein accumulation as a fluorometric functional assay of the multidrug transporter.
    Holló Z; Homolya L; Davis CW; Sarkadi B
    Biochim Biophys Acta; 1994 May; 1191(2):384-8. PubMed ID: 7909692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
    Hu Z; Zhou Z; Hu Y; Wu J; Li Y; Huang W
    PLoS One; 2015; 10(2):e0116886. PubMed ID: 25689592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
    Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference.
    Ansbro MR; Shukla S; Ambudkar SV; Yuspa SH; Li L
    PLoS One; 2013; 8(4):e60334. PubMed ID: 23593196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
    Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E
    Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
    Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
    Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells.
    Holló Z; Homolya L; Hegedüs T; Sarkadi B
    FEBS Lett; 1996 Mar; 383(1-2):99-104. PubMed ID: 8612802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity.
    Laupeze B; Amiot L; Courtois A; Vernhet L; Drenou B; Fauchet R; Fardel O
    Int J Oncol; 1999 Sep; 15(3):571-6. PubMed ID: 10427142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells.
    Wielinga PR; Heijn M; Broxterman HJ; Lankelma J
    Biochem Pharmacol; 1997 Oct; 54(7):791-9. PubMed ID: 9353133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells.
    Utoguchi N; Chandorkar GA; Avery M; Audus KL
    Reprod Toxicol; 2000; 14(3):217-24. PubMed ID: 10838122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
    Draper MP; Martell RL; Levy SB
    Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
    Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
    Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.